Applied Clinical Trials-10-01-2010

Pharmacists and patient groups welcome the new European Union directive on pharmacovigilance.

Updates on the pian drugs market.

Collecting too many metrics can lead to misappropriation and misinterpretation.

Industry news focusing on the people and organizations who work in the clinical trials profession.

S

Routine inspections and regulations can help maintain GCP standards in global trials.

Reform law requires tracking and disclosure of fees to investigators and research consultants.

Access to all available medical evidence can profoundly improve treatment effectiveness.

Clinical grant expenditures represent a major portion of the budget for later phase clinical trials.

Waiving inclusion/exclusion criteria affects investigators, subjects, sponsors, and the trial itself.

The act creates serious concerns about the industry's ability to recruit and retain well-qualified investigators.

Knowing when to outsource and when to conduct pharmacovigilance in-house is a crucial decision.